drugset / Trial / NCT02918097
Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive Episode
NaSequentialOpen-labelTreatment
Summary
To evaluate the effectiveness of an algorithm for Bipolar Disorder depressive episodes (BDD) using medications available in the Brazilian Public Healthcare System (SUS). Quality of life assessment of these patients was also employed. A randomized pragmatic trial was conducted. An algorithm was developed for the treatment of episodes of bipolar disorder depression episodes.
Timeline
- Start
- 2010-05
- Primary completion
- 2014-11
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lithium Carbonate | Unknown | 900 mg | — |
| Subject | Lithium Carbonate | Unknown | 1500 mg | — |
| Subject | Nortriptyline | Small molecule | 100 mg | — |
| Subject | Risperidone | Other / unclassified | 1 mg | — |
| Subject | Risperidone | Other / unclassified | 6 mg | — |
| Subject | Sertraline | Small molecule | 50 mg | — |
| Subject | Sertraline | Small molecule | 100 mg | — |
| Subject | Sertraline | Small molecule | 200 mg | — |